Brain cell transplant trial offers hope for Parkinson's patients
NCT ID NCT05635409
First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 17 times
Summary
This early-stage trial tests whether transplanting lab-grown dopamine-producing cells into the brain is safe for people with Parkinson's disease. Eight participants with moderate Parkinson's will receive a single dose of these stem cells. The study focuses on safety and looks for early signs that the treatment might help control symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cambridge University Hospitals NHS Foundation Trust
Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom
-
Region Skåne - Skåne University Hospital
Lund, 214 28, Sweden
Conditions
Explore the condition pages connected to this study.